Oral Drug Delivery Resources

1. Improved Biomanufacturing Processes And Drug Product Stability 9/20/2022

   Improve upstream media for bioavailability and foam stability, downstream buffers for purification, and the formulation and final fill drug product stability with this highly interdisciplinary process.

2. Development Of Next Gen Sustained Release Solutions For Pain Management 2/22/2023

   A TheraPEA™ polymer based injectable formulation designed to deliver the same dose of Triamcinolone Acetonide (TAA) as in Zilretta^® has shown promising results in a series of pre-clinical studies.

3. A Clinical Assessment Of Delayed-Release Coated Capsule Compositions For Regional Gastrointestinal Delivery Using Gamma Scintigraphy 3/7/2022

   Gamma scintigraphy was used to evaluate GI transit and release from 3 capsule prototypes with different coating systems; data on pH, temperature and pressure during GI transit was obtained and correlated.

4. Reshaping Drug Development With 3D Screen Printing 8/15/2025

   Steven Facer and Laxxon Medical COO Klaus Kühne describe the capabilities of 3D screen printing for pharmaceutical production. Explore prototyping, IP protection, release profile possibilities, and more.

5. Evolution Of Novel Polymers To Overcome Limits In Sustained Drug Delivery 10/24/2022

   Degradable polymers evolved from aliphatic polyesters to nitrogen-bearing biomaterials such as polyurethanes and polyester amides. Explore a brief history of the development of PEA polymers.

6. 3D Screen Printing: Enabling A New Generation Of Complex Formulations 3/17/2025

   Screen-Printed Innovative Drug Technology can produce oral, transdermal, and implantable dosage forms while ensuring heterogeneous distribution of active ingredients.

7. Age-Appropriate Pediatric Formulation Development 1/27/2022

   There is a significant variability in the pharmacokinetics of the same drug and dosage form between pediatric and adult populations, and the factors impacting drug bioavailability are different in children.

8. Accelerate Development Of Enabled Formulations For Poorly Soluble Drugs 8/21/2023

   Explore how a platform integrating drug substance, drug product, and clinical testing within a single organization accelerates development and reduces costs, helping deliver positive outcomes earlier.

9. Understanding Of Amorphous Solid Dispersions & Their Downstream Development 2/7/2022

   Understanding the properties of ASDs and their relationship to the downstream product scale up, stability, and in-vivo performance is critical to successfully utilize them for drug delivery of insoluble drugs.

10. Streamline Early-Stage Development To Reach The Clinic Faster 7/17/2023

    Early-stage development is an iterative process, continuously generating new data and insights to optimize the product based on emerging knowledge.